These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23560053)
1. Enhancing specific-antibody production to the ragB vaccine with GITRL that expand Tfh, IFN-γ(+) T cells and attenuates Porphyromonas gingivalis infection in mice. Zheng D; Sun Q; Su Z; Kong F; Shi X; Tong J; Shen P; Peng T; Wang S; Xu H PLoS One; 2013; 8(4):e59604. PubMed ID: 23560053 [TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis B cell Antigen Epitope Vaccine, pIRES-ragB'-mGITRL, Promoted RagB-Specific Antibody Production and Tfh Cells Expansion. Kong F; Zheng D; She P; Ni P; Zhu H; Xu H; Su Z Scand J Immunol; 2015 Jun; 81(6):476-82. PubMed ID: 25689343 [TBL] [Abstract][Full Text] [Related]
3. [Construction of eukaryotic co-expression vector of Porphyromonas gingivalis outer membrane protein ragB and glucocorticoid-induced tumor necrosis factor receptor ligand (GITRL) and its immunogenic analysis]. Kong FZ; Zheng D; Su ZL; She P; Xu XX; Tian SS; Zhang P; Chen JG; Xu HX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):588-91. PubMed ID: 22691349 [TBL] [Abstract][Full Text] [Related]
4. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity. Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628 [TBL] [Abstract][Full Text] [Related]
5. Immunization by Arg-gingipain A DNA vaccine protects mice against an invasive Porphyromonas gingivalis infection through regulation of interferon-gamma production. Yonezawa H; Kato T; Kuramitsu HK; Okuda K; Ishihara K Oral Microbiol Immunol; 2005 Oct; 20(5):259-66. PubMed ID: 16101960 [TBL] [Abstract][Full Text] [Related]
6. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K Front Immunol; 2021; 12():634923. PubMed ID: 33717178 [TBL] [Abstract][Full Text] [Related]
7. GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity. Yuan J; Tang X; Yin K; Tian J; Rui K; Ma J; Mao C; Chen J; Lu L; Xu H; Wang S Immunol Res; 2015 May; 62(1):81-8. PubMed ID: 25772201 [TBL] [Abstract][Full Text] [Related]
8. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model. Katz J; Black KP; Michalek SM Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874 [TBL] [Abstract][Full Text] [Related]
9. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice. Gemmell E; Winning TA; Grieco DA; Bird PS; Seymour GJ J Periodontol; 2000 Jul; 71(7):1130-8. PubMed ID: 10960020 [TBL] [Abstract][Full Text] [Related]
10. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Yonezawa H; Ishihara K; Okuda K Infect Immun; 2001 May; 69(5):2858-64. PubMed ID: 11292699 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis. Yang QB; Martin M; Michalek SM; Katz J Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496 [TBL] [Abstract][Full Text] [Related]
12. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Kuboniwa M; Amano A; Shizukuishi S; Nakagawa I; Hamada S Infect Immun; 2001 May; 69(5):2972-9. PubMed ID: 11292714 [TBL] [Abstract][Full Text] [Related]
13. Genetic dependence of the specific T-cell cytokine response to Porphyromonas gingivalis in mice. Gemmell E; Carter CL; Bird PS; Seymour GJ J Periodontol; 2002 Jun; 73(6):591-6. PubMed ID: 12083530 [TBL] [Abstract][Full Text] [Related]
14. Construction of a sIgA-enhancing anti-Porphyromonas gingivalis FimA vaccine and nasal immunization in mice. Guo H; Wang X; Jiang G; Yang P Immunol Lett; 2006 Sep; 107(1):71-5. PubMed ID: 16959327 [TBL] [Abstract][Full Text] [Related]
16. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513 [TBL] [Abstract][Full Text] [Related]
17. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model. Herminajeng E; Sosroseno W; Bird PS; Seymour GJ J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864 [TBL] [Abstract][Full Text] [Related]
18. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755 [TBL] [Abstract][Full Text] [Related]
19. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. Gemmell E; Winning TA; Bird PS; Seymour GJ J Periodontol; 1998 Oct; 69(10):1131-8. PubMed ID: 9802713 [TBL] [Abstract][Full Text] [Related]
20. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity. Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]